Stay updated on IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New trial sites have been added in Heidelberg, Amsterdam, Andalusia, Catalonia, Horta de València, and Madrid. Several previously listed locations were removed.
    Difference
    0.7%
    Check dated 2025-12-23T10:41:51.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Minor revision: v3.3.2 replaces v3.2.0; this does not alter any study content or page purpose. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:49:38.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The government funding/operating status notice at the top of the page has been removed; core study details and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T17:33:43.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The updates shown are cosmetic UI/layout changes with no edits to the study's core content (title, NCT ID, interventions, outcomes, or eligibility criteria). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:08:39.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T16:44:56.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-28T10:00:24.000Z thumbnail image

Stay in the know with updates to IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.